Key facts
- AMI’s last known valuation is $40.1M (May 2025).
- It has raised $21.5M; the latest was Later Stage VC ($6.0M) in May 2025.
- Notable investors include MedTech Innovator, SBI Investment, Japan External Trade Organization, UntroD, Development Bank of Japan — 25 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 25 names
- ·Watchlist + deal alerts for AMI
- ·The full record, as it builds
Funding rounds
No funding rounds for AMI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AMI
Operator of a medical innovation business intended to change auscultation and enable accessible, non-invasive cardiac assessment anytime and anywhere. The company offers proprietary medical hardware, simultaneous acquisition of heart sounds and electrocardiograms, machine learning-based diagnostic support, and remote data sharing capabilities, enabling healthcare professionals and medical institutions to support task shifting and telemedicine with improved cardiac insight and clinical decision support.
- Sector
- Healthcare
- HQ
- Kagoshima, Japan
- Founded
- 2015
- Employees
- 43
- Website
- ami.inc/
- Ownership
- Privately Held (backing)
AMI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AMI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AMI in its N-PORT filings yet. We sweep new filings monthly.